世界の生分解性塞栓マイクロスフェア市場予測 2023年-2029年

【英語タイトル】Global Biodegradable Embolic Microspheres Market Growth 2023-2029

LP Informationが出版した調査資料(LP23DC06932)・商品コード:LP23DC06932
・発行会社(調査会社):LP Information
・発行日:2023年11月
・ページ数:112
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療機器&消耗品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の生分解性塞栓マイクロスフェア市場」は、過去の販売実績から2022年の世界の生分解性塞栓マイクロスフェアの総販売量を検討し、2023年から2029年の予測される生分解性塞栓マイクロスフェアの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の生分解性塞栓マイクロスフェアの市場規模を掲載し、XXX百万米ドル規模の世界の生分解性塞栓マイクロスフェア市場の詳細な分析を提供します。本インサイトレポートは、世界の生分解性塞栓マイクロスフェア業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の生分解性塞栓マイクロスフェア市場における各社の独自のポジションをより深く理解するために、生分解性塞栓マイクロスフェア製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の生分解性塞栓マイクロスフェア市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。生分解性塞栓マイクロスフェアの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。生分解性塞栓マイクロスフェアの中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。生分解性塞栓マイクロスフェアのヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

生分解性塞栓マイクロスフェアの世界主要メーカーとしては、Biocompatibles、 Nippon Kayaku、 Varian、 Next Biomedical、 Mermaid Medical、 CeloNova BioSciences、 Biosphere Medical、 Promedics AG、 Merit Medical Systems、 ABK Biomedical、 BTG Corporate、 Teleflex、 Terumo Corporation、 Tepha、 Angio Dynamics、 Occlugel、 Jiangsu Hengrui Medicineなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の生分解性塞栓マイクロスフェア市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では生分解性塞栓マイクロスフェア市場をセグメンテーションし、種類別 (可視化型、放射性、環境対応型、その他)、用途別 (病院&診療所、研究機関)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:可視化型、放射性、環境対応型、その他

・用途別区分:病院&診療所、研究機関

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界の生分解性塞栓マイクロスフェア市場の10年間の市場状況・展望は?
・世界および地域別に見た生分解性塞栓マイクロスフェア市場成長の要因は何か?
・生分解性塞栓マイクロスフェアの市場機会はエンドマーケットの規模によってどのように変化するのか?
・生分解性塞栓マイクロスフェアのタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:生分解性塞栓マイクロスフェアの年間販売量2018-2029、地域別現状・将来分析
・生分解性塞栓マイクロスフェアの種類別セグメント:可視化型、放射性、環境対応型、その他
・生分解性塞栓マイクロスフェアの種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・生分解性塞栓マイクロスフェアの用途別セグメント:病院&診療所、研究機関
・生分解性塞栓マイクロスフェアの用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の生分解性塞栓マイクロスフェア市場
・企業別のグローバル生分解性塞栓マイクロスフェア市場データ:2018-2023年の年間販売量、市場シェア
・企業別の生分解性塞栓マイクロスフェアの年間売上:2018-2023年の売上、市場シェア
・企業別の生分解性塞栓マイクロスフェア販売価格
・主要企業の生分解性塞栓マイクロスフェア生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

生分解性塞栓マイクロスフェアの地域別レビュー
・地域別の生分解性塞栓マイクロスフェア市場規模2018-2023:年間販売量、売上
・主要国別の生分解性塞栓マイクロスフェア市場規模2018-2023:年間販売量、売上
・南北アメリカの生分解性塞栓マイクロスフェア販売の成長
・アジア太平洋の生分解性塞栓マイクロスフェア販売の成長
・ヨーロッパの生分解性塞栓マイクロスフェア販売の成長
・中東・アフリカの生分解性塞栓マイクロスフェア販売の成長

南北アメリカ市場
・南北アメリカの国別の生分解性塞栓マイクロスフェア販売量、売上(2018-2023)
・南北アメリカの生分解性塞栓マイクロスフェアの種類別販売量
・南北アメリカの生分解性塞栓マイクロスフェアの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の生分解性塞栓マイクロスフェア販売量、売上(2018-2023)
・アジア太平洋の生分解性塞栓マイクロスフェアの種類別販売量
・アジア太平洋の生分解性塞栓マイクロスフェアの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の生分解性塞栓マイクロスフェア販売量、売上(2018-2023)
・ヨーロッパの生分解性塞栓マイクロスフェアの種類別販売量
・ヨーロッパの生分解性塞栓マイクロスフェアの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の生分解性塞栓マイクロスフェア販売量、売上(2018-2023)
・中東・アフリカの生分解性塞栓マイクロスフェアの種類別販売量
・中東・アフリカの生分解性塞栓マイクロスフェアの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・生分解性塞栓マイクロスフェアの製造コスト構造分析
・生分解性塞栓マイクロスフェアの製造プロセス分析
・生分解性塞栓マイクロスフェアの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・生分解性塞栓マイクロスフェアの主要なグローバル販売業者
・生分解性塞栓マイクロスフェアの主要なグローバル顧客

地域別の生分解性塞栓マイクロスフェア市場予測レビュー
・地域別の生分解性塞栓マイクロスフェア市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・生分解性塞栓マイクロスフェアの種類別市場規模予測
・生分解性塞栓マイクロスフェアの用途別市場規模予測

主要企業分析
Biocompatibles、 Nippon Kayaku、 Varian、 Next Biomedical、 Mermaid Medical、 CeloNova BioSciences、 Biosphere Medical、 Promedics AG、 Merit Medical Systems、 ABK Biomedical、 BTG Corporate、 Teleflex、 Terumo Corporation、 Tepha、 Angio Dynamics、 Occlugel、 Jiangsu Hengrui Medicine
・企業情報
・生分解性塞栓マイクロスフェア製品
・生分解性塞栓マイクロスフェア販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

The global Biodegradable Embolic Microspheres market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Biodegradable Embolic Microspheres is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Biodegradable Embolic Microspheres is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Biodegradable Embolic Microspheres is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Biodegradable Embolic Microspheres players cover Biocompatibles, Nippon Kayaku, Varian, Next Biomedical, Mermaid Medical, CeloNova BioSciences, Biosphere Medical, Promedics AG and Merit Medical Systems, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Biodegradable Embolic Microspheres are indicated for use in hemostatic embolization and in embolization of arteriovenous malformations, hypervascular tumors, including uterine fibroids and meningiomas, and the prostate arteries for relief of symptoms related to Benign Prostatic Hyperplasia (BPH).
LPI (LP Information)’ newest research report, the “Biodegradable Embolic Microspheres Industry Forecast” looks at past sales and reviews total world Biodegradable Embolic Microspheres sales in 2022, providing a comprehensive analysis by region and market sector of projected Biodegradable Embolic Microspheres sales for 2023 through 2029. With Biodegradable Embolic Microspheres sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biodegradable Embolic Microspheres industry.
This Insight Report provides a comprehensive analysis of the global Biodegradable Embolic Microspheres landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biodegradable Embolic Microspheres portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biodegradable Embolic Microspheres market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biodegradable Embolic Microspheres and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biodegradable Embolic Microspheres.
This report presents a comprehensive overview, market shares, and growth opportunities of Biodegradable Embolic Microspheres market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Visualization Type
Radioactive Type
Environmentally Responsive Type
Other
Segmentation by application
Hospitals And Clinics
Research Institution
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Biocompatibles
Nippon Kayaku
Varian
Next Biomedical
Mermaid Medical
CeloNova BioSciences
Biosphere Medical
Promedics AG
Merit Medical Systems
ABK Biomedical
BTG Corporate
Teleflex
Terumo Corporation
Tepha
Angio Dynamics
Occlugel
Jiangsu Hengrui Medicine
Key Questions Addressed in this Report
What is the 10-year outlook for the global Biodegradable Embolic Microspheres market?
What factors are driving Biodegradable Embolic Microspheres market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biodegradable Embolic Microspheres market opportunities vary by end market size?
How does Biodegradable Embolic Microspheres break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biodegradable Embolic Microspheres Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Biodegradable Embolic Microspheres by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Biodegradable Embolic Microspheres by Country/Region, 2018, 2022 & 2029
2.2 Biodegradable Embolic Microspheres Segment by Type
2.2.1 Visualization Type
2.2.2 Radioactive Type
2.2.3 Environmentally Responsive Type
2.2.4 Other
2.3 Biodegradable Embolic Microspheres Sales by Type
2.3.1 Global Biodegradable Embolic Microspheres Sales Market Share by Type (2018-2023)
2.3.2 Global Biodegradable Embolic Microspheres Revenue and Market Share by Type (2018-2023)
2.3.3 Global Biodegradable Embolic Microspheres Sale Price by Type (2018-2023)
2.4 Biodegradable Embolic Microspheres Segment by Application
2.4.1 Hospitals And Clinics
2.4.2 Research Institution
2.5 Biodegradable Embolic Microspheres Sales by Application
2.5.1 Global Biodegradable Embolic Microspheres Sale Market Share by Application (2018-2023)
2.5.2 Global Biodegradable Embolic Microspheres Revenue and Market Share by Application (2018-2023)
2.5.3 Global Biodegradable Embolic Microspheres Sale Price by Application (2018-2023)
3 Global Biodegradable Embolic Microspheres by Company
3.1 Global Biodegradable Embolic Microspheres Breakdown Data by Company
3.1.1 Global Biodegradable Embolic Microspheres Annual Sales by Company (2018-2023)
3.1.2 Global Biodegradable Embolic Microspheres Sales Market Share by Company (2018-2023)
3.2 Global Biodegradable Embolic Microspheres Annual Revenue by Company (2018-2023)
3.2.1 Global Biodegradable Embolic Microspheres Revenue by Company (2018-2023)
3.2.2 Global Biodegradable Embolic Microspheres Revenue Market Share by Company (2018-2023)
3.3 Global Biodegradable Embolic Microspheres Sale Price by Company
3.4 Key Manufacturers Biodegradable Embolic Microspheres Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biodegradable Embolic Microspheres Product Location Distribution
3.4.2 Players Biodegradable Embolic Microspheres Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Biodegradable Embolic Microspheres by Geographic Region
4.1 World Historic Biodegradable Embolic Microspheres Market Size by Geographic Region (2018-2023)
4.1.1 Global Biodegradable Embolic Microspheres Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Biodegradable Embolic Microspheres Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Biodegradable Embolic Microspheres Market Size by Country/Region (2018-2023)
4.2.1 Global Biodegradable Embolic Microspheres Annual Sales by Country/Region (2018-2023)
4.2.2 Global Biodegradable Embolic Microspheres Annual Revenue by Country/Region (2018-2023)
4.3 Americas Biodegradable Embolic Microspheres Sales Growth
4.4 APAC Biodegradable Embolic Microspheres Sales Growth
4.5 Europe Biodegradable Embolic Microspheres Sales Growth
4.6 Middle East & Africa Biodegradable Embolic Microspheres Sales Growth
5 Americas
5.1 Americas Biodegradable Embolic Microspheres Sales by Country
5.1.1 Americas Biodegradable Embolic Microspheres Sales by Country (2018-2023)
5.1.2 Americas Biodegradable Embolic Microspheres Revenue by Country (2018-2023)
5.2 Americas Biodegradable Embolic Microspheres Sales by Type
5.3 Americas Biodegradable Embolic Microspheres Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biodegradable Embolic Microspheres Sales by Region
6.1.1 APAC Biodegradable Embolic Microspheres Sales by Region (2018-2023)
6.1.2 APAC Biodegradable Embolic Microspheres Revenue by Region (2018-2023)
6.2 APAC Biodegradable Embolic Microspheres Sales by Type
6.3 APAC Biodegradable Embolic Microspheres Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Biodegradable Embolic Microspheres by Country
7.1.1 Europe Biodegradable Embolic Microspheres Sales by Country (2018-2023)
7.1.2 Europe Biodegradable Embolic Microspheres Revenue by Country (2018-2023)
7.2 Europe Biodegradable Embolic Microspheres Sales by Type
7.3 Europe Biodegradable Embolic Microspheres Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biodegradable Embolic Microspheres by Country
8.1.1 Middle East & Africa Biodegradable Embolic Microspheres Sales by Country (2018-2023)
8.1.2 Middle East & Africa Biodegradable Embolic Microspheres Revenue by Country (2018-2023)
8.2 Middle East & Africa Biodegradable Embolic Microspheres Sales by Type
8.3 Middle East & Africa Biodegradable Embolic Microspheres Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biodegradable Embolic Microspheres
10.3 Manufacturing Process Analysis of Biodegradable Embolic Microspheres
10.4 Industry Chain Structure of Biodegradable Embolic Microspheres
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biodegradable Embolic Microspheres Distributors
11.3 Biodegradable Embolic Microspheres Customer
12 World Forecast Review for Biodegradable Embolic Microspheres by Geographic Region
12.1 Global Biodegradable Embolic Microspheres Market Size Forecast by Region
12.1.1 Global Biodegradable Embolic Microspheres Forecast by Region (2024-2029)
12.1.2 Global Biodegradable Embolic Microspheres Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biodegradable Embolic Microspheres Forecast by Type
12.7 Global Biodegradable Embolic Microspheres Forecast by Application
13 Key Players Analysis
13.1 Biocompatibles
13.1.1 Biocompatibles Company Information
13.1.2 Biocompatibles Biodegradable Embolic Microspheres Product Portfolios and Specifications
13.1.3 Biocompatibles Biodegradable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Biocompatibles Main Business Overview
13.1.5 Biocompatibles Latest Developments
13.2 Nippon Kayaku
13.2.1 Nippon Kayaku Company Information
13.2.2 Nippon Kayaku Biodegradable Embolic Microspheres Product Portfolios and Specifications
13.2.3 Nippon Kayaku Biodegradable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Nippon Kayaku Main Business Overview
13.2.5 Nippon Kayaku Latest Developments
13.3 Varian
13.3.1 Varian Company Information
13.3.2 Varian Biodegradable Embolic Microspheres Product Portfolios and Specifications
13.3.3 Varian Biodegradable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Varian Main Business Overview
13.3.5 Varian Latest Developments
13.4 Next Biomedical
13.4.1 Next Biomedical Company Information
13.4.2 Next Biomedical Biodegradable Embolic Microspheres Product Portfolios and Specifications
13.4.3 Next Biomedical Biodegradable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Next Biomedical Main Business Overview
13.4.5 Next Biomedical Latest Developments
13.5 Mermaid Medical
13.5.1 Mermaid Medical Company Information
13.5.2 Mermaid Medical Biodegradable Embolic Microspheres Product Portfolios and Specifications
13.5.3 Mermaid Medical Biodegradable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mermaid Medical Main Business Overview
13.5.5 Mermaid Medical Latest Developments
13.6 CeloNova BioSciences
13.6.1 CeloNova BioSciences Company Information
13.6.2 CeloNova BioSciences Biodegradable Embolic Microspheres Product Portfolios and Specifications
13.6.3 CeloNova BioSciences Biodegradable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 CeloNova BioSciences Main Business Overview
13.6.5 CeloNova BioSciences Latest Developments
13.7 Biosphere Medical
13.7.1 Biosphere Medical Company Information
13.7.2 Biosphere Medical Biodegradable Embolic Microspheres Product Portfolios and Specifications
13.7.3 Biosphere Medical Biodegradable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Biosphere Medical Main Business Overview
13.7.5 Biosphere Medical Latest Developments
13.8 Promedics AG
13.8.1 Promedics AG Company Information
13.8.2 Promedics AG Biodegradable Embolic Microspheres Product Portfolios and Specifications
13.8.3 Promedics AG Biodegradable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Promedics AG Main Business Overview
13.8.5 Promedics AG Latest Developments
13.9 Merit Medical Systems
13.9.1 Merit Medical Systems Company Information
13.9.2 Merit Medical Systems Biodegradable Embolic Microspheres Product Portfolios and Specifications
13.9.3 Merit Medical Systems Biodegradable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Merit Medical Systems Main Business Overview
13.9.5 Merit Medical Systems Latest Developments
13.10 ABK Biomedical
13.10.1 ABK Biomedical Company Information
13.10.2 ABK Biomedical Biodegradable Embolic Microspheres Product Portfolios and Specifications
13.10.3 ABK Biomedical Biodegradable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 ABK Biomedical Main Business Overview
13.10.5 ABK Biomedical Latest Developments
13.11 BTG Corporate
13.11.1 BTG Corporate Company Information
13.11.2 BTG Corporate Biodegradable Embolic Microspheres Product Portfolios and Specifications
13.11.3 BTG Corporate Biodegradable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 BTG Corporate Main Business Overview
13.11.5 BTG Corporate Latest Developments
13.12 Teleflex
13.12.1 Teleflex Company Information
13.12.2 Teleflex Biodegradable Embolic Microspheres Product Portfolios and Specifications
13.12.3 Teleflex Biodegradable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Teleflex Main Business Overview
13.12.5 Teleflex Latest Developments
13.13 Terumo Corporation
13.13.1 Terumo Corporation Company Information
13.13.2 Terumo Corporation Biodegradable Embolic Microspheres Product Portfolios and Specifications
13.13.3 Terumo Corporation Biodegradable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Terumo Corporation Main Business Overview
13.13.5 Terumo Corporation Latest Developments
13.14 Tepha
13.14.1 Tepha Company Information
13.14.2 Tepha Biodegradable Embolic Microspheres Product Portfolios and Specifications
13.14.3 Tepha Biodegradable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Tepha Main Business Overview
13.14.5 Tepha Latest Developments
13.15 Angio Dynamics
13.15.1 Angio Dynamics Company Information
13.15.2 Angio Dynamics Biodegradable Embolic Microspheres Product Portfolios and Specifications
13.15.3 Angio Dynamics Biodegradable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Angio Dynamics Main Business Overview
13.15.5 Angio Dynamics Latest Developments
13.16 Occlugel
13.16.1 Occlugel Company Information
13.16.2 Occlugel Biodegradable Embolic Microspheres Product Portfolios and Specifications
13.16.3 Occlugel Biodegradable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Occlugel Main Business Overview
13.16.5 Occlugel Latest Developments
13.17 Jiangsu Hengrui Medicine
13.17.1 Jiangsu Hengrui Medicine Company Information
13.17.2 Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Product Portfolios and Specifications
13.17.3 Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Jiangsu Hengrui Medicine Main Business Overview
13.17.5 Jiangsu Hengrui Medicine Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Biodegradable Embolic Microspheres Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Biodegradable Embolic Microspheres Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Visualization Type
Table 4. Major Players of Radioactive Type
Table 5. Major Players of Environmentally Responsive Type
Table 6. Major Players of Other
Table 7. Global Biodegradable Embolic Microspheres Sales by Type (2018-2023) & (K Tons)
Table 8. Global Biodegradable Embolic Microspheres Sales Market Share by Type (2018-2023)
Table 9. Global Biodegradable Embolic Microspheres Revenue by Type (2018-2023) & ($ million)
Table 10. Global Biodegradable Embolic Microspheres Revenue Market Share by Type (2018-2023)
Table 11. Global Biodegradable Embolic Microspheres Sale Price by Type (2018-2023) & (US$/Ton)
Table 12. Global Biodegradable Embolic Microspheres Sales by Application (2018-2023) & (K Tons)
Table 13. Global Biodegradable Embolic Microspheres Sales Market Share by Application (2018-2023)
Table 14. Global Biodegradable Embolic Microspheres Revenue by Application (2018-2023)
Table 15. Global Biodegradable Embolic Microspheres Revenue Market Share by Application (2018-2023)
Table 16. Global Biodegradable Embolic Microspheres Sale Price by Application (2018-2023) & (US$/Ton)
Table 17. Global Biodegradable Embolic Microspheres Sales by Company (2018-2023) & (K Tons)
Table 18. Global Biodegradable Embolic Microspheres Sales Market Share by Company (2018-2023)
Table 19. Global Biodegradable Embolic Microspheres Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Biodegradable Embolic Microspheres Revenue Market Share by Company (2018-2023)
Table 21. Global Biodegradable Embolic Microspheres Sale Price by Company (2018-2023) & (US$/Ton)
Table 22. Key Manufacturers Biodegradable Embolic Microspheres Producing Area Distribution and Sales Area
Table 23. Players Biodegradable Embolic Microspheres Products Offered
Table 24. Biodegradable Embolic Microspheres Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Biodegradable Embolic Microspheres Sales by Geographic Region (2018-2023) & (K Tons)
Table 28. Global Biodegradable Embolic Microspheres Sales Market Share Geographic Region (2018-2023)
Table 29. Global Biodegradable Embolic Microspheres Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Biodegradable Embolic Microspheres Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Biodegradable Embolic Microspheres Sales by Country/Region (2018-2023) & (K Tons)
Table 32. Global Biodegradable Embolic Microspheres Sales Market Share by Country/Region (2018-2023)
Table 33. Global Biodegradable Embolic Microspheres Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Biodegradable Embolic Microspheres Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Biodegradable Embolic Microspheres Sales by Country (2018-2023) & (K Tons)
Table 36. Americas Biodegradable Embolic Microspheres Sales Market Share by Country (2018-2023)
Table 37. Americas Biodegradable Embolic Microspheres Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Biodegradable Embolic Microspheres Revenue Market Share by Country (2018-2023)
Table 39. Americas Biodegradable Embolic Microspheres Sales by Type (2018-2023) & (K Tons)
Table 40. Americas Biodegradable Embolic Microspheres Sales by Application (2018-2023) & (K Tons)
Table 41. APAC Biodegradable Embolic Microspheres Sales by Region (2018-2023) & (K Tons)
Table 42. APAC Biodegradable Embolic Microspheres Sales Market Share by Region (2018-2023)
Table 43. APAC Biodegradable Embolic Microspheres Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Biodegradable Embolic Microspheres Revenue Market Share by Region (2018-2023)
Table 45. APAC Biodegradable Embolic Microspheres Sales by Type (2018-2023) & (K Tons)
Table 46. APAC Biodegradable Embolic Microspheres Sales by Application (2018-2023) & (K Tons)
Table 47. Europe Biodegradable Embolic Microspheres Sales by Country (2018-2023) & (K Tons)
Table 48. Europe Biodegradable Embolic Microspheres Sales Market Share by Country (2018-2023)
Table 49. Europe Biodegradable Embolic Microspheres Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Biodegradable Embolic Microspheres Revenue Market Share by Country (2018-2023)
Table 51. Europe Biodegradable Embolic Microspheres Sales by Type (2018-2023) & (K Tons)
Table 52. Europe Biodegradable Embolic Microspheres Sales by Application (2018-2023) & (K Tons)
Table 53. Middle East & Africa Biodegradable Embolic Microspheres Sales by Country (2018-2023) & (K Tons)
Table 54. Middle East & Africa Biodegradable Embolic Microspheres Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Biodegradable Embolic Microspheres Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Biodegradable Embolic Microspheres Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Biodegradable Embolic Microspheres Sales by Type (2018-2023) & (K Tons)
Table 58. Middle East & Africa Biodegradable Embolic Microspheres Sales by Application (2018-2023) & (K Tons)
Table 59. Key Market Drivers & Growth Opportunities of Biodegradable Embolic Microspheres
Table 60. Key Market Challenges & Risks of Biodegradable Embolic Microspheres
Table 61. Key Industry Trends of Biodegradable Embolic Microspheres
Table 62. Biodegradable Embolic Microspheres Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Biodegradable Embolic Microspheres Distributors List
Table 65. Biodegradable Embolic Microspheres Customer List
Table 66. Global Biodegradable Embolic Microspheres Sales Forecast by Region (2024-2029) & (K Tons)
Table 67. Global Biodegradable Embolic Microspheres Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Biodegradable Embolic Microspheres Sales Forecast by Country (2024-2029) & (K Tons)
Table 69. Americas Biodegradable Embolic Microspheres Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Biodegradable Embolic Microspheres Sales Forecast by Region (2024-2029) & (K Tons)
Table 71. APAC Biodegradable Embolic Microspheres Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Biodegradable Embolic Microspheres Sales Forecast by Country (2024-2029) & (K Tons)
Table 73. Europe Biodegradable Embolic Microspheres Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Biodegradable Embolic Microspheres Sales Forecast by Country (2024-2029) & (K Tons)
Table 75. Middle East & Africa Biodegradable Embolic Microspheres Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Biodegradable Embolic Microspheres Sales Forecast by Type (2024-2029) & (K Tons)
Table 77. Global Biodegradable Embolic Microspheres Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Biodegradable Embolic Microspheres Sales Forecast by Application (2024-2029) & (K Tons)
Table 79. Global Biodegradable Embolic Microspheres Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Biocompatibles Basic Information, Biodegradable Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 81. Biocompatibles Biodegradable Embolic Microspheres Product Portfolios and Specifications
Table 82. Biocompatibles Biodegradable Embolic Microspheres Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 83. Biocompatibles Main Business
Table 84. Biocompatibles Latest Developments
Table 85. Nippon Kayaku Basic Information, Biodegradable Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 86. Nippon Kayaku Biodegradable Embolic Microspheres Product Portfolios and Specifications
Table 87. Nippon Kayaku Biodegradable Embolic Microspheres Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 88. Nippon Kayaku Main Business
Table 89. Nippon Kayaku Latest Developments
Table 90. Varian Basic Information, Biodegradable Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 91. Varian Biodegradable Embolic Microspheres Product Portfolios and Specifications
Table 92. Varian Biodegradable Embolic Microspheres Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 93. Varian Main Business
Table 94. Varian Latest Developments
Table 95. Next Biomedical Basic Information, Biodegradable Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 96. Next Biomedical Biodegradable Embolic Microspheres Product Portfolios and Specifications
Table 97. Next Biomedical Biodegradable Embolic Microspheres Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 98. Next Biomedical Main Business
Table 99. Next Biomedical Latest Developments
Table 100. Mermaid Medical Basic Information, Biodegradable Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 101. Mermaid Medical Biodegradable Embolic Microspheres Product Portfolios and Specifications
Table 102. Mermaid Medical Biodegradable Embolic Microspheres Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 103. Mermaid Medical Main Business
Table 104. Mermaid Medical Latest Developments
Table 105. CeloNova BioSciences Basic Information, Biodegradable Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 106. CeloNova BioSciences Biodegradable Embolic Microspheres Product Portfolios and Specifications
Table 107. CeloNova BioSciences Biodegradable Embolic Microspheres Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 108. CeloNova BioSciences Main Business
Table 109. CeloNova BioSciences Latest Developments
Table 110. Biosphere Medical Basic Information, Biodegradable Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 111. Biosphere Medical Biodegradable Embolic Microspheres Product Portfolios and Specifications
Table 112. Biosphere Medical Biodegradable Embolic Microspheres Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 113. Biosphere Medical Main Business
Table 114. Biosphere Medical Latest Developments
Table 115. Promedics AG Basic Information, Biodegradable Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 116. Promedics AG Biodegradable Embolic Microspheres Product Portfolios and Specifications
Table 117. Promedics AG Biodegradable Embolic Microspheres Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 118. Promedics AG Main Business
Table 119. Promedics AG Latest Developments
Table 120. Merit Medical Systems Basic Information, Biodegradable Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 121. Merit Medical Systems Biodegradable Embolic Microspheres Product Portfolios and Specifications
Table 122. Merit Medical Systems Biodegradable Embolic Microspheres Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 123. Merit Medical Systems Main Business
Table 124. Merit Medical Systems Latest Developments
Table 125. ABK Biomedical Basic Information, Biodegradable Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 126. ABK Biomedical Biodegradable Embolic Microspheres Product Portfolios and Specifications
Table 127. ABK Biomedical Biodegradable Embolic Microspheres Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 128. ABK Biomedical Main Business
Table 129. ABK Biomedical Latest Developments
Table 130. BTG Corporate Basic Information, Biodegradable Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 131. BTG Corporate Biodegradable Embolic Microspheres Product Portfolios and Specifications
Table 132. BTG Corporate Biodegradable Embolic Microspheres Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 133. BTG Corporate Main Business
Table 134. BTG Corporate Latest Developments
Table 135. Teleflex Basic Information, Biodegradable Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 136. Teleflex Biodegradable Embolic Microspheres Product Portfolios and Specifications
Table 137. Teleflex Biodegradable Embolic Microspheres Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 138. Teleflex Main Business
Table 139. Teleflex Latest Developments
Table 140. Terumo Corporation Basic Information, Biodegradable Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 141. Terumo Corporation Biodegradable Embolic Microspheres Product Portfolios and Specifications
Table 142. Terumo Corporation Biodegradable Embolic Microspheres Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 143. Terumo Corporation Main Business
Table 144. Terumo Corporation Latest Developments
Table 145. Tepha Basic Information, Biodegradable Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 146. Tepha Biodegradable Embolic Microspheres Product Portfolios and Specifications
Table 147. Tepha Biodegradable Embolic Microspheres Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 148. Tepha Main Business
Table 149. Tepha Latest Developments
Table 150. Angio Dynamics Basic Information, Biodegradable Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 151. Angio Dynamics Biodegradable Embolic Microspheres Product Portfolios and Specifications
Table 152. Angio Dynamics Biodegradable Embolic Microspheres Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 153. Angio Dynamics Main Business
Table 154. Angio Dynamics Latest Developments
Table 155. Occlugel Basic Information, Biodegradable Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 156. Occlugel Biodegradable Embolic Microspheres Product Portfolios and Specifications
Table 157. Occlugel Biodegradable Embolic Microspheres Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 158. Occlugel Main Business
Table 159. Occlugel Latest Developments
Table 160. Jiangsu Hengrui Medicine Basic Information, Biodegradable Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 161. Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Product Portfolios and Specifications
Table 162. Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 163. Jiangsu Hengrui Medicine Main Business
Table 164. Jiangsu Hengrui Medicine Latest Developments
List of Figures
Figure 1. Picture of Biodegradable Embolic Microspheres
Figure 2. Biodegradable Embolic Microspheres Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biodegradable Embolic Microspheres Sales Growth Rate 2018-2029 (K Tons)
Figure 7. Global Biodegradable Embolic Microspheres Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Biodegradable Embolic Microspheres Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Visualization Type
Figure 10. Product Picture of Radioactive Type
Figure 11. Product Picture of Environmentally Responsive Type
Figure 12. Product Picture of Other
Figure 13. Global Biodegradable Embolic Microspheres Sales Market Share by Type in 2022
Figure 14. Global Biodegradable Embolic Microspheres Revenue Market Share by Type (2018-2023)
Figure 15. Biodegradable Embolic Microspheres Consumed in Hospitals And Clinics
Figure 16. Global Biodegradable Embolic Microspheres Market: Hospitals And Clinics (2018-2023) & (K Tons)
Figure 17. Biodegradable Embolic Microspheres Consumed in Research Institution
Figure 18. Global Biodegradable Embolic Microspheres Market: Research Institution (2018-2023) & (K Tons)
Figure 19. Global Biodegradable Embolic Microspheres Sales Market Share by Application (2022)
Figure 20. Global Biodegradable Embolic Microspheres Revenue Market Share by Application in 2022
Figure 21. Biodegradable Embolic Microspheres Sales Market by Company in 2022 (K Tons)
Figure 22. Global Biodegradable Embolic Microspheres Sales Market Share by Company in 2022
Figure 23. Biodegradable Embolic Microspheres Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Biodegradable Embolic Microspheres Revenue Market Share by Company in 2022
Figure 25. Global Biodegradable Embolic Microspheres Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Biodegradable Embolic Microspheres Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Biodegradable Embolic Microspheres Sales 2018-2023 (K Tons)
Figure 28. Americas Biodegradable Embolic Microspheres Revenue 2018-2023 ($ Millions)
Figure 29. APAC Biodegradable Embolic Microspheres Sales 2018-2023 (K Tons)
Figure 30. APAC Biodegradable Embolic Microspheres Revenue 2018-2023 ($ Millions)
Figure 31. Europe Biodegradable Embolic Microspheres Sales 2018-2023 (K Tons)
Figure 32. Europe Biodegradable Embolic Microspheres Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Biodegradable Embolic Microspheres Sales 2018-2023 (K Tons)
Figure 34. Middle East & Africa Biodegradable Embolic Microspheres Revenue 2018-2023 ($ Millions)
Figure 35. Americas Biodegradable Embolic Microspheres Sales Market Share by Country in 2022
Figure 36. Americas Biodegradable Embolic Microspheres Revenue Market Share by Country in 2022
Figure 37. Americas Biodegradable Embolic Microspheres Sales Market Share by Type (2018-2023)
Figure 38. Americas Biodegradable Embolic Microspheres Sales Market Share by Application (2018-2023)
Figure 39. United States Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Biodegradable Embolic Microspheres Sales Market Share by Region in 2022
Figure 44. APAC Biodegradable Embolic Microspheres Revenue Market Share by Regions in 2022
Figure 45. APAC Biodegradable Embolic Microspheres Sales Market Share by Type (2018-2023)
Figure 46. APAC Biodegradable Embolic Microspheres Sales Market Share by Application (2018-2023)
Figure 47. China Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Biodegradable Embolic Microspheres Sales Market Share by Country in 2022
Figure 55. Europe Biodegradable Embolic Microspheres Revenue Market Share by Country in 2022
Figure 56. Europe Biodegradable Embolic Microspheres Sales Market Share by Type (2018-2023)
Figure 57. Europe Biodegradable Embolic Microspheres Sales Market Share by Application (2018-2023)
Figure 58. Germany Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Biodegradable Embolic Microspheres Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Biodegradable Embolic Microspheres Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Biodegradable Embolic Microspheres Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Biodegradable Embolic Microspheres Sales Market Share by Application (2018-2023)
Figure 67. Egypt Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Biodegradable Embolic Microspheres Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Biodegradable Embolic Microspheres in 2022
Figure 73. Manufacturing Process Analysis of Biodegradable Embolic Microspheres
Figure 74. Industry Chain Structure of Biodegradable Embolic Microspheres
Figure 75. Channels of Distribution
Figure 76. Global Biodegradable Embolic Microspheres Sales Market Forecast by Region (2024-2029)
Figure 77. Global Biodegradable Embolic Microspheres Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Biodegradable Embolic Microspheres Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Biodegradable Embolic Microspheres Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Biodegradable Embolic Microspheres Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Biodegradable Embolic Microspheres Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の生分解性塞栓マイクロスフェア市場予測 2023年-2029年] (コード:LP23DC06932)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の生分解性塞栓マイクロスフェア市場予測 2023年-2029年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆